codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop

Breakdown of CDXS holdings in ARKG. See current position, past trades, and weighting changes

A protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics.

Date	Direction	Shares	Fund Weight	Fund

January 11, 2023	BUY	108.612k	0.0307%	ARKG
January 10, 2023	BUY	86.293k	0.0247%	ARKG
January 6, 2023	BUY	18.141k	0.0048%	ARKG
January 5, 2023	BUY	27.315k	0.0069%	ARKG
January 3, 2023	BUY	50.433k	0.0122%	ARKG

⚖️Weighting	🧢Market Cap
0.48%	$160.24m
🏋🏿‍♂️Weight Rank In ARKG	🌏Country
38	🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds	💳ARK Estimated Cost Average
103
🎫ARK Ownership Percent
6.17%

Description
A protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics.
Website
codexis.com

Ticker	Name	Weight

ARKG	ARK Genomic Revolution ETF	0.93%
IBB	iShares Biotechnology ETF	0.03%

ARKG Holdings of Codexis (CDXS) - Updated Daily

Trades of CDXS Made In ARKG

Key Statistics

Other ETFs That Hold CDXS

Research Notes and Commentary for CDXS